Identità

N-Nitroso Nitrendipine

Non indicato · C18H19N3O7

01Identità

Lazychem IDLC-22192
CAS RNNon indicato
PubChem CID176482436
Molecular formulaC18H19N3O7
Molecular weight389.36 g/mol
IUPAC name3-ethyl 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1-nitroso-1,4-dihydropyridine-3,5-dicarboxylate
InChIKeyNATMOZCOFCOGCF-UHFFFAOYSA-N

02Struttura e stereochimica

2D structurePubChem CID 176482436
Two-dimensional chemical structure of N-Nitroso Nitrendipine
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 2 rings, includes aromatic atoms, includes aliphatic carbon, contains an N-nitroso substructure, contains a nitro substructure. These statements are calculated from the published structure string.

Defined stereocentres0
Ring count2
Secondary amines0
Tertiary amines1
SMILESCC(N(N=O)C(C)=C1C(OC)=O)=C(C(OCC)=O)C1C2=CC=CC([N+]([O-])=O)=C2
InChINon indicato

03Stereochemistry

The published structure contains 0 defined and 1 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.

Defined centres0Structure assigned
Unassigned centres1Structure unspecified
Assignment statusUnassignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Stato in India

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Nomi e relazioni

API e farmaco progenitore

Nitrendipine

Impurezze e composti correlati

Nomi e relazioni

    Impurezze e composti correlati

    06Fonti